Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Dynamic regulatory network controlling TH17 cell differentiation.
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Race to Erase MS Forum and Expo
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Good Early Results for HERV Suppressor in MS
Remyelination therapy goes to trial for multiple sclerosis
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
4-aminopyridine toxicity: a case report and review of the literature.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging.

Pages